Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 02, 2026 01:57 ET | Source: Qoder

Qoder Introduces Time-of-Day Credits Pricing for Qwen3.7-Max and Qwen3.7-Plus

Qoder launches off-peak Credits pricing for Qwen3.7-Max and Plus, reducing AI coding costs across its product suite.
July 02, 2026 01:30 ET | Source: TomTom International BV US

TomTom and Transit Technologies partner to deliver enhanced fleet and logistics operations

AMSTERDAM, July 02, 2026 (GLOBE NEWSWIRE) -- TomTom (TOM2), the specialist in mapping and location technology, and Transit Technologies, a leading provider of software solutions powering mobility...
July 02, 2026 01:30 ET | Source: BOUYGUES

Bouygues Construction acquires Vannoy Construction, securing lasting presence in the United States

Press releaseJuly 2, 2026 Bouygues Construction acquires Vannoy Construction, securing lasting presence in the United States © Bouygues ConstructionFrom left to right in the...
July 02, 2026 01:04 ET | Source: ISS World Services A/S

ISS extends and expands partnership with public healthcare provider in Southern Europe

Copenhagen, July 02, 2026 (GLOBE NEWSWIRE) -- Under the agreement, ISS will expand its current cleaning services to include additional services while also increasing the scope of cleaning across the...
July 02, 2026 01:03 ET | Source: Insta Group

Insta and CHAOS Industries Partner to Counter Rising Aerial Threats in Europe

TAMPERE, FINLAND & LOS ANGELES, CA, USA., July 02, 2026 (GLOBE NEWSWIRE) -- Partnership brings distributed sensing and effects to Finland and Northern Europe to address ongoing threats of...
July 02, 2026 01:00 ET | Source: F. Hoffmann-La Roche Ltd

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer

Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed clinically meaningful improvements in...
July 02, 2026 01:00 ET | Source: Promon

LexisNexis Risk Solutions and Promon Align to Strengthen Mobile Fraud Prevention

LexisNexis Risk Solutions and Promon ally to strengthen mobile fraud prevention by combining risk intelligence with in-app protection.
July 02, 2026 01:00 ET | Source: Sodexo SA

Q3 Fiscal 2026 revenues above expectations; focus on execution

Issy-les-Moulineaux, July 2, 2026 (7:00 a.m. CEST)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Q3 organic revenue growth of +2.0%Revised Fiscal 2026 organic revenue growth guidance, reflecting...
July 02, 2026 01:00 ET | Source: GlobeNewswire, Inc.

Start of Day Message

LONDON, 02 Jul. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
July 02, 2026 01:00 ET | Source: Molecular Partners

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712 Dosing ongoing in first patients, consecutively moving to subsequent dosing cyclesInitial data anticipated within...